This compound is a chemical compound used as a pharmaceutical intermediate in the manufacturing of active pharmaceutical ingredients. It features an aromatic ether and a tertiary amine functional group.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 83015-25-2
Rac N-Methyl Atomoxetine Oxalate
Pharmaceutical intermediate for atomoxetine derivative
N-Nitroso-Atomoxetine
Nitrosamine impurity reference standard
N-[2-fluoro-6-(trifluoromethyl)benzyl]urea
Pharmaceutical intermediate
1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methylpyrimidine-2,4-dione
Pharmaceutical intermediate
5-bromo-1-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-6-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
Pharmaceutical intermediate
1,1-Dimethylethyl N-[(1R)-2-[5-bromo-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]carbamate
pharmaceutical intermediate
N,N-dimethyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine
UCPQMRYBCNDVHU-UHFFFAOYSA-N
CC1=CC=CC=C1OC(CCN(C)C)C2=CC=CC=C2
—